Concepts (153)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Acetaminophen | 5 | 2018 | 552 | 1.240 |
Why?
|
| Propylene Glycol | 2 | 2018 | 30 | 1.050 |
Why?
|
| Poisoning | 3 | 2023 | 252 | 0.830 |
Why?
|
| Akathisia, Drug-Induced | 2 | 2016 | 66 | 0.830 |
Why?
|
| beta-Alanine | 2 | 2013 | 82 | 0.780 |
Why?
|
| Fentanyl | 3 | 2020 | 451 | 0.780 |
Why?
|
| Antithrombins | 3 | 2017 | 294 | 0.780 |
Why?
|
| Alcoholics | 1 | 2021 | 1 | 0.750 |
Why?
|
| Methanol | 1 | 2021 | 91 | 0.710 |
Why?
|
| Drug Contamination | 1 | 2021 | 151 | 0.660 |
Why?
|
| Cytochrome P-450 CYP2E1 | 1 | 2018 | 41 | 0.620 |
Why?
|
| Warfarin | 3 | 2015 | 1493 | 0.570 |
Why?
|
| Benzimidazoles | 2 | 2013 | 864 | 0.550 |
Why?
|
| Intracranial Hemorrhage, Traumatic | 1 | 2017 | 54 | 0.540 |
Why?
|
| Anticoagulants | 3 | 2017 | 4852 | 0.520 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 2018 | 371 | 0.490 |
Why?
|
| Substance Withdrawal Syndrome | 1 | 2020 | 628 | 0.480 |
Why?
|
| Coma | 1 | 2018 | 485 | 0.470 |
Why?
|
| Analgesics, Opioid | 3 | 2021 | 3837 | 0.460 |
Why?
|
| Intracranial Hemorrhages | 3 | 2017 | 810 | 0.440 |
Why?
|
| Nausea | 1 | 2016 | 682 | 0.440 |
Why?
|
| Vomiting | 1 | 2016 | 655 | 0.430 |
Why?
|
| Pruritus | 1 | 2016 | 379 | 0.430 |
Why?
|
| Blood Coagulation Factors | 1 | 2015 | 371 | 0.420 |
Why?
|
| Designer Drugs | 1 | 2012 | 21 | 0.420 |
Why?
|
| Trazodone | 1 | 2012 | 67 | 0.410 |
Why?
|
| Excipients | 1 | 2013 | 96 | 0.410 |
Why?
|
| Craniocerebral Trauma | 1 | 2017 | 493 | 0.410 |
Why?
|
| Hemorrhage | 3 | 2017 | 3467 | 0.400 |
Why?
|
| Morphine | 1 | 2016 | 658 | 0.400 |
Why?
|
| Amphetamine-Related Disorders | 1 | 2012 | 80 | 0.400 |
Why?
|
| Emergency Service, Hospital | 7 | 2021 | 7951 | 0.390 |
Why?
|
| Salicylates | 1 | 2011 | 128 | 0.370 |
Why?
|
| Hypokalemia | 1 | 2011 | 152 | 0.350 |
Why?
|
| Nonprescription Drugs | 1 | 2011 | 119 | 0.350 |
Why?
|
| Alcoholism | 1 | 2021 | 1980 | 0.340 |
Why?
|
| Pyridones | 1 | 2015 | 819 | 0.340 |
Why?
|
| Diphenhydramine | 1 | 2009 | 63 | 0.320 |
Why?
|
| Accidental Falls | 1 | 2017 | 1080 | 0.320 |
Why?
|
| Chlorpheniramine | 1 | 2007 | 13 | 0.300 |
Why?
|
| Speech Disorders | 1 | 2009 | 179 | 0.300 |
Why?
|
| Phenylpropanolamine | 1 | 2007 | 15 | 0.300 |
Why?
|
| Serotonin Syndrome | 1 | 2007 | 18 | 0.300 |
Why?
|
| Alcohol Drinking | 1 | 2021 | 4045 | 0.290 |
Why?
|
| Dextromethorphan | 1 | 2007 | 37 | 0.290 |
Why?
|
| Acetylcysteine | 1 | 2009 | 262 | 0.290 |
Why?
|
| Patient Admission | 1 | 2015 | 1365 | 0.290 |
Why?
|
| Caffeine | 2 | 2012 | 703 | 0.290 |
Why?
|
| Amnesia | 2 | 2020 | 257 | 0.280 |
Why?
|
| Serotonin Agents | 1 | 2006 | 29 | 0.270 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 2 | 2013 | 2271 | 0.250 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2017 | 2763 | 0.240 |
Why?
|
| Opioid-Related Disorders | 1 | 2020 | 2188 | 0.240 |
Why?
|
| Pyrazoles | 1 | 2015 | 2028 | 0.240 |
Why?
|
| Citalopram | 1 | 2007 | 401 | 0.230 |
Why?
|
| Cocaine-Related Disorders | 1 | 2007 | 458 | 0.220 |
Why?
|
| Venous Thromboembolism | 1 | 2015 | 1883 | 0.200 |
Why?
|
| Piperazines | 1 | 2012 | 2554 | 0.200 |
Why?
|
| Propofol | 1 | 2007 | 608 | 0.190 |
Why?
|
| Medication Adherence | 1 | 2012 | 2187 | 0.180 |
Why?
|
| Antidepressive Agents | 1 | 2012 | 2913 | 0.180 |
Why?
|
| Fat Emulsions, Intravenous | 1 | 2023 | 314 | 0.180 |
Why?
|
| Hypnotics and Sedatives | 1 | 2007 | 1191 | 0.160 |
Why?
|
| Cross-Over Studies | 2 | 2018 | 2107 | 0.160 |
Why?
|
| Hospitals, Urban | 1 | 2021 | 497 | 0.160 |
Why?
|
| Syndrome | 2 | 2020 | 3272 | 0.150 |
Why?
|
| Dietary Supplements | 1 | 2011 | 3445 | 0.150 |
Why?
|
| Motion Sickness | 1 | 2016 | 33 | 0.140 |
Why?
|
| Aspartate Aminotransferases | 1 | 2018 | 414 | 0.140 |
Why?
|
| Fatal Outcome | 1 | 2021 | 1836 | 0.130 |
Why?
|
| Drug Interactions | 2 | 2018 | 1419 | 0.130 |
Why?
|
| Alanine Transaminase | 1 | 2018 | 606 | 0.130 |
Why?
|
| France | 1 | 2016 | 497 | 0.120 |
Why?
|
| Humans | 27 | 2023 | 768166 | 0.110 |
Why?
|
| Acid-Base Equilibrium | 1 | 2014 | 180 | 0.110 |
Why?
|
| Dosage Forms | 1 | 2013 | 56 | 0.110 |
Why?
|
| Pharmacoepidemiology | 1 | 2016 | 351 | 0.110 |
Why?
|
| Osmolar Concentration | 1 | 2014 | 657 | 0.100 |
Why?
|
| Ethylene Glycols | 1 | 2014 | 198 | 0.100 |
Why?
|
| Sleep Stages | 1 | 2016 | 706 | 0.100 |
Why?
|
| Suicide, Attempted | 2 | 2014 | 1409 | 0.100 |
Why?
|
| Atrial Fibrillation | 3 | 2017 | 5176 | 0.100 |
Why?
|
| Male | 15 | 2023 | 364719 | 0.100 |
Why?
|
| Sulfates | 1 | 2013 | 379 | 0.100 |
Why?
|
| Female | 17 | 2023 | 397192 | 0.100 |
Why?
|
| Drug Prescriptions | 1 | 2021 | 1668 | 0.090 |
Why?
|
| Trauma Centers | 1 | 2017 | 951 | 0.090 |
Why?
|
| Logistic Models | 2 | 2016 | 13290 | 0.090 |
Why?
|
| Partial Thromboplastin Time | 1 | 2011 | 204 | 0.090 |
Why?
|
| Adult | 12 | 2023 | 223646 | 0.090 |
Why?
|
| Mental Disorders | 2 | 2012 | 6874 | 0.090 |
Why?
|
| Ischemic Attack, Transient | 1 | 2015 | 877 | 0.080 |
Why?
|
| Prospective Studies | 4 | 2023 | 54926 | 0.080 |
Why?
|
| Area Under Curve | 1 | 2013 | 1643 | 0.080 |
Why?
|
| Aged | 8 | 2023 | 171504 | 0.080 |
Why?
|
| Hippocampus | 1 | 2020 | 3785 | 0.070 |
Why?
|
| Administration, Oral | 1 | 2015 | 4030 | 0.070 |
Why?
|
| Ventricular Dysfunction | 1 | 2008 | 144 | 0.070 |
Why?
|
| Spinal Puncture | 1 | 2009 | 286 | 0.070 |
Why?
|
| Venous Thrombosis | 1 | 2015 | 1323 | 0.060 |
Why?
|
| Retrospective Studies | 5 | 2021 | 81762 | 0.060 |
Why?
|
| Myocardial Infarction | 1 | 2006 | 11519 | 0.060 |
Why?
|
| Risk | 1 | 2017 | 9613 | 0.060 |
Why?
|
| Odds Ratio | 1 | 2016 | 9669 | 0.060 |
Why?
|
| Middle Aged | 8 | 2023 | 223492 | 0.060 |
Why?
|
| Multivariate Analysis | 1 | 2016 | 12077 | 0.050 |
Why?
|
| Infusions, Intravenous | 1 | 2007 | 2230 | 0.050 |
Why?
|
| Aged, 80 and over | 3 | 2021 | 59629 | 0.050 |
Why?
|
| Domestic Violence | 1 | 2004 | 180 | 0.050 |
Why?
|
| Renal Dialysis | 1 | 2011 | 1791 | 0.050 |
Why?
|
| Stroke | 2 | 2015 | 9755 | 0.050 |
Why?
|
| Pulmonary Embolism | 1 | 2015 | 2599 | 0.050 |
Why?
|
| Drug Combinations | 1 | 2007 | 2089 | 0.050 |
Why?
|
| Registries | 1 | 2017 | 8375 | 0.050 |
Why?
|
| Acute Kidney Injury | 1 | 2013 | 1942 | 0.040 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2017 | 20760 | 0.040 |
Why?
|
| Weight Loss | 1 | 2011 | 2721 | 0.040 |
Why?
|
| Length of Stay | 1 | 2013 | 6498 | 0.040 |
Why?
|
| Risk Factors | 2 | 2016 | 74944 | 0.040 |
Why?
|
| Young Adult | 3 | 2023 | 60066 | 0.040 |
Why?
|
| Incidence | 1 | 2017 | 21538 | 0.040 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2008 | 2258 | 0.040 |
Why?
|
| Cohort Studies | 2 | 2021 | 41754 | 0.040 |
Why?
|
| Aspirin | 1 | 2008 | 3135 | 0.030 |
Why?
|
| Age Factors | 1 | 2013 | 18412 | 0.030 |
Why?
|
| Electrocardiography | 1 | 2009 | 6412 | 0.030 |
Why?
|
| Clinical Trials as Topic | 1 | 2011 | 8054 | 0.030 |
Why?
|
| Adolescent | 4 | 2021 | 89169 | 0.030 |
Why?
|
| Diagnosis, Differential | 1 | 2009 | 13014 | 0.030 |
Why?
|
| Acidosis | 1 | 2014 | 271 | 0.020 |
Why?
|
| Forecasting | 1 | 2021 | 2945 | 0.020 |
Why?
|
| Erythrocyte Transfusion | 1 | 2017 | 575 | 0.020 |
Why?
|
| Substance-Related Disorders | 1 | 2007 | 4423 | 0.020 |
Why?
|
| Critical Illness | 1 | 2023 | 2756 | 0.020 |
Why?
|
| Attitude of Health Personnel | 1 | 2004 | 3929 | 0.020 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2017 | 1126 | 0.020 |
Why?
|
| Pediatrics | 1 | 2004 | 3629 | 0.020 |
Why?
|
| United States | 1 | 2016 | 73039 | 0.020 |
Why?
|
| Massachusetts | 1 | 2021 | 8890 | 0.020 |
Why?
|
| Hemofiltration | 1 | 2008 | 58 | 0.020 |
Why?
|
| Acute Disease | 1 | 2018 | 7243 | 0.020 |
Why?
|
| Lorazepam | 1 | 2008 | 155 | 0.020 |
Why?
|
| Algorithms | 1 | 2007 | 14164 | 0.020 |
Why?
|
| Ethanol | 1 | 2012 | 1331 | 0.020 |
Why?
|
| Anti-Anxiety Agents | 1 | 2008 | 405 | 0.020 |
Why?
|
| Internship and Residency | 1 | 2004 | 5953 | 0.010 |
Why?
|
| Psychotic Disorders | 1 | 2018 | 3276 | 0.010 |
Why?
|
| Nervous System Diseases | 1 | 2012 | 1662 | 0.010 |
Why?
|
| Health Care Surveys | 1 | 2004 | 2434 | 0.010 |
Why?
|
| Mass Screening | 1 | 2004 | 5458 | 0.000 |
Why?
|
| Cardiovascular Diseases | 1 | 2012 | 15662 | 0.000 |
Why?
|
| Child | 1 | 2012 | 80917 | 0.000 |
Why?
|
| Treatment Outcome | 1 | 2008 | 65371 | 0.000 |
Why?
|
Concepts
(153)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(9)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_